Brief: Myriad Genetics Says Settlement Was Approved By The Court In Myriad Genetics, Inc. Stockholder Derivative Litigation
26/11/2024 22:43
Nov 26 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS INC - SETTLEMENT WAS APPROVED BY THE COURT
IN
MYRIAD GENETICS, INC. STOCKHOLDER DERIVATIVE LITIGATION
* MYRIAD GENETICS INC - COURT'S ORDER DISMISSED CONSOLIDATED
DERIVATIVE ACTION WITH PREJUDICE
Source text: ID:n0000899923-24-000060
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple